Abstract
Glucocorticoid receptors (GR) and 3-O-methyl-D glucose (3-O-MG) transport were determined in mononuclear leukocytes (MNL) from 11 abdominal obese subjects, 10 pituitary-dependent Cushing’s syndrome (Cushing’s disease) and 10 healthy controls. Using a whole-cell competitive binding assay and 3H-dexamethasone as tracer, MNL of abdominal obese subjects were found to have 4855±1389 sites/cell which was significantly lower (p<0.05) than controls (6234±1568 sites/cell), although no significant difference was found in the mean serum cortisol level. Their mean Kd (affinity) was also significantly lower than that found in the healthy controls (obese Kd:2.92±0.84nmol/I, control Kd: 4.55±0.67nM, p<0.05). On the other hand, the receptor characteristics in Cushing’s disease patients were within the normal range. At the same time, 3-O-MG transport was determined in the same subjects. In Cushing’s disease, 3-O-MG transport was within the normal range, whereas in abdominal obesity this value was significantly lower than the healthy controls (abdominal obese: 31.90±8.20; control: 46.26±12.91 fmol/106cell. min, p<0.05). We also found a positive correlation between 3-O-MG transport and GR binding capacity in abdominal subjects (r=0.89, p<0.001), however we did not find such a correlation in Cushing’s disease (r=0.60, p>0.05). These results indicated that, in abdominal obesity, the GR binding capacity in MNL is influenced by the changes in glucose transport.
Similar content being viewed by others
References
Proietto J., Thorburn A.W. Animal models of obesity-theories of aetiology. Baillieres Clin. Endocrinol. 8: 509, 1994.
Salans L.B. The obesities. In: Felig P., Baxter J.D., Broadus A.E., Frohman L.A. (Eds.), Endocrinology and Metabolism. McGraw-Hill Book Company, New York, 1981, p. 891.
Kopelman P.G. Hormones and obesity. Baillieres Clin. Endocrinol. 8: 549, 1994.
Tyrrell J.B., Forsham P.H. Glucocorticoid & adrenal androgens. In: Greenspan F.S., Forsham P.H. (Eds.), Basic & Clinical Endocrinology. Lange Medical Publications, Los Altos, California, 1984, p. 258.
Howlett T.A., Rees L.H., Besser G.M. Cushing’s syndrome. Clin. Endocrinol. Metab. 14: 911, 1985.
Von Werder K., Müller O.A. Cushing’s syndrome. In: Grossman A. (Ed.), Clinical Endocrinology. Blackwell Scientific Publications, Oxford, 1992, p. 442.
Tappy L., Randin D., Vollenweider P., Vollenweider L., Paquot N., Scherrer U., Schneiter P., Nicod P., Jequier E. Mechanisms of dexamethasone-induced insulin resistance in healthy humans. J. Clin. Endocrinol. Metab. 79: 1063, 1994.
Tanaka H., Akama H., Ichikawa Y., Homma M., Makino I. Glucocorticoid receptor and inhibition of 3-O-methyl-D-glucose uptake by glucocorticoids in peripheral blood leukocytes from normal humans: correlation between receptor level and hormone effect in vitro. Acta Endocrinol. (Copenh.) 126: 29, 1992.
Gurwitz J.H., Bohn R.L., Glynn R.J., Monane M., Mogun H., Avorn J. Glucocorticoids and the risk for initiation of hypoglycemic therapy. Arch. Intern. Med. 154: 97, 1994.
Bray G. Fat distribution and body weight. Ob. Res. 1: 203, 1993.
Tanaka H., Akama H., Ichikawa Y., Homma M., Oshima H. Glucocorticoid receptors in normal leukocytes: effects of age, gender, season and plasma cortisol concentrations. Clin. Chem. 37: 1715, 1991.
Damm P., Binder C. Glucocorticoid receptors in monocytes in type 1 diabetes mellitus. Clin. Chim. Acta 184: 167, 1989.
Scatchard G. The attractions of proteins by small molecules and ions. Ann. N.Y. Acad. Sci. 51: 660, 1949.
Brentani M.M., Wajchenberg B.L., Cesar F.P., Martins V.R. Regulation of the glucocorticoid receptor by glucocorticoids in human mononuclear leukocytes. Horm. Res. 24: 9, 1986.
Pardes E., De Yampey J.E., Moses D.F., De Nicola A.F. Regulation of glucocorticoid receptors in human mononuclear cells: Effects of glucocorticoid treatment, Cushing’s disease and ketoconazole. J. Steroid Biochem. 39: 233, 1991.
Girardin E., Garoscio-Cholet M., Dechaud H., Lejeune H., Carrier E., Tourniaire J., Pugeat M. Glucocorticoid receptors in lymphocytes in anorexia nervosa. Clin. Endocrinol. (Oxf.) 35: 79, 1991.
Kontula K., Pelkonen R., Andersson L., Sivula A. Glucocorticoid receptors in adrenocorticoid disorders. J. Clin. Endocrinol. Metab. 51: 654, 1980.
Schlechte J.A., Sherman B.M. Decreased glucocorticoid receptor binding in adrenal insufficiency. J. Clin. Endocrinol. Metab. 54: 145, 1982.
Haber R.S., Weinstein S.P. Role of glucose transporters in glucocorticoid-induced insulin resistance: GLUT 4 isoform in rat skeletal muscle is not decreased by dexamethasone. Diabetes 41: 728, 1992.
Yanovski J.A., Culter G.B. Glucocorticoid action and clinical features of Cushing’s syndrome. Endocrinol. Metab. Clin. North Am. 23: 487, 1994.
Weaver J.U., Hitman G.A., Kopelman P.G. An association between a Bcll restriction fragment length polymorphism of glucocorticoid receptor locus and hyperinsulinemia in obese women. J. Mol. Endocrinol. 9: 295, 1992.
Slavnov V.N., Epshtein E.V. Somatotrophic, thyrotrophic and adrenotrophic functions of the anterior pituitary in obesity. Endocrinologie 19: 213, 1977.
Tsai H.J., Romsos D.R. Glucocorticoid and mineralocorticoid receptor-binding characteristics in obese (ob/ob) mice. Am. J. Physiol. 261: 499, 1991.
Webb M.L., Flynn J.J., Schmidt T.J., Margules D.L., Litwack G. Decreased glucocorticoid binding and receptor activation in brain of genetically diabetic (mdb/mdb) mice. J. Steroid Biochem. 25: 649, 1986.
Shargill N.S., Al-Baker I., York D.A. Normal levels of serum corticosterone and hepatic glucocorticoid receptors in obese (fa/fa) rats. Biosci. Rep. 7: 843, 1987.
Svec F. Glucocorticoid receptor regulation. Life Sci. 36: 2359, 1985.
Bodwell J.E., Hu L.M., Munck A. Glucocorticoid receptors; ATP-dependent cycling and hormone-dependent hyperphosphorilation. J. Steroid Biochem. 47: 31, 1993.
Wheeler R.H., Leach K.L., La Forest A.C., O’Toole T.E., Pratt W.B. Glucocorticoid receptor activation and inactivation in cultured human lymphocytes. J. Biol. Chem. 256: 434, 1981.
Amatruda J.M., Livingston J.N., Lockwood D.H. Cellular mechanisms in selected states of insulin resistance: human obesity, glucocorticoid excess and chronic renal failure. Diabetes Metab. Rev. 1: 293, 1985.
Cooney G.J., Storlien L.H. Insulin action, thermogenesis and obesity. Baillieres Clin. Endocrinol. Metab. 8: 481, 1994.
Ramsey T.G. Fat cells. Endoc. Metab. Clin. 25: 847, 1996.
Daneman D., Zinman B., Elliott M.E., Bilan P.J., Klip A. Insulin-stimulated glucose transport in circulating mononuclear cells from nondiabetic and IDDM subjects. Diabetes 41: 227, 1992.
Garvey W.T., Birnbaum M.J. Cellular action and insulin resistance. Baillieres Clin. Endocrinol. Metab. 7: 785, 1993.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Güven, M., Hatemi, H., Taşan, E. et al. The modulation of glucocorticoid receptor content by 3-O-methyl-D-glucose transport in human mononuclear leukocyte in obesity. J Endocrinol Invest 21, 656–661 (1998). https://doi.org/10.1007/BF03350794
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350794